Bank of America
BJDX icon

Bank of America’s Bluejay Diagnostics BJDX Stock Holding History

Bank of America’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$10 – 5836
2025
Q4 		$10 Buy
4
+1
+33% +$7 ﹤0.01% 7196
2025
Q3 		$18 Buy
3
+2
+200% +$12 ﹤0.01% 8171
2025
Q2 		$9 Hold
1
– – ﹤0.01% 8300
2025
Q1 		$15 Hold
1
– – ﹤0.01% 8175
2024
Q4 		$19 Buy
+1
New +$19 ﹤0.01% 8030
2024
Q3 		– Hold
0
– – – 8077
2023
Q1 		– Hold
0
– -$4 – 7815
2022
Q4 		– Hold
0
– – – 8141

Other funds holding BJDX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $149M AUM
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Bank of America's BJDX Position: Q1 2026 in Review

Bank of America sold out of Bluejay Diagnostics (BJDX) in Q1 2026, closing a stake of 4 shares — an estimated $10 sold.

Bank of America first reported a position in BJDX in Q4 2024 and held it in 5 quarters. The position peaked at $19 in Q4 2024. 6 funds tracked by Wall St. Rank hold BJDX as of Q1 2026.

  • Bank of America reported no remaining Bluejay Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 4 Bluejay Diagnostics shares in Q1 2026, an estimated $10.
  • Bank of America first reported a position in Bluejay Diagnostics in Q4 2024 and held it in 5 quarters.
  • Bank of America's Bluejay Diagnostics position peaked at $19 in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.